Role and therapeutic potential of CDK12 in human cancers
- 14 September 2016
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 50, 83-88
- https://doi.org/10.1016/j.ctrv.2016.09.003
Abstract
No abstract availableFunding Information
- Italian Association for Cancer Research (IG14536)
This publication has 52 references indexed in Scilit:
- A DNA Damage Response System Associated with the phosphoCTD of Elongating RNA Polymerase IIPLOS ONE, 2013
- CTD serine-2 plays a critical role in splicing and termination factor recruitment to RNA polymerase II in vivoNucleic Acids Research, 2012
- Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase IIMolecular and Cellular Biology, 2012
- Cyclin K goes with Cdk12 and Cdk13Cell Division, 2012
- The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genesGenes & Development, 2011
- Ending the message: poly(A) signals then and nowGenes & Development, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1Genes & Development, 2010
- SR Proteins in Vertical Integration of Gene Expression from Transcription to RNA Processing to TranslationMolecular Cell, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009